We are international
Donate
• videos TEXT SIZE   
webcasts from medical meetings    back

A Phase I/II Study of Revlimid, Adriamycin, and Dexamethasone (RAD) in Patients with Relapsed/Refractory Myeloma
By Stefan Knop, MD
Stefan Knop, MD
Universitätsklinikums Würzburg (University Clinic of Wuerzburg)
Würzburg, Germany
12.23.06
A Phase I/II Study of Revlimid, Adriamycin, and Dexamethasone (RAD) in Patients with Relapsed/Refractory Myeloma



 related articles